Tanfac Industries Ltd
Incorporated in 1972, Tanfac Industries Ltd is amongst the leading producers of Hydrofluoric Acid and its derivatives.
- Market Cap ₹ 3,810 Cr.
- Current Price ₹ 3,820
- High / Low ₹ 5,064 / 2,510
- Stock P/E 50.9
- Book Value ₹ 340
- Dividend Yield 0.23 %
- ROCE 41.8 %
- ROE 32.0 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company is expected to give good quarter
- Company has delivered good profit growth of 38.6% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 30.1%
Cons
- Stock is trading at 11.1 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Part of BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117 | 120 | 133 | 126 | 162 | 222 | 165 | 148 | 320 | 375 | 378 | 557 | 690 | |
| 106 | 112 | 125 | 112 | 141 | 169 | 138 | 115 | 244 | 299 | 306 | 426 | 572 | |
| Operating Profit | 11 | 8 | 9 | 14 | 21 | 53 | 27 | 33 | 76 | 76 | 72 | 131 | 117 |
| OPM % | 10% | 7% | 7% | 11% | 13% | 24% | 16% | 22% | 24% | 20% | 19% | 24% | 17% |
| 0 | 1 | 4 | 1 | 0 | 1 | 1 | 1 | 3 | 8 | 7 | 3 | 3 | |
| Interest | 10 | 10 | 8 | 7 | 7 | 4 | 2 | 1 | 2 | 2 | 2 | 5 | 5 |
| Depreciation | 7 | 6 | 5 | 5 | 5 | 8 | 5 | 8 | 6 | 6 | 7 | 10 | 17 |
| Profit before tax | -6 | -7 | 0 | 3 | 10 | 42 | 22 | 25 | 72 | 75 | 70 | 119 | 99 |
| Tax % | -45% | -20% | -8% | 0% | 1% | 14% | 22% | 30% | 26% | 26% | 25% | 26% | |
| -3 | -5 | 0 | 3 | 10 | 36 | 17 | 17 | 53 | 56 | 52 | 88 | 75 | |
| EPS in Rs | -3.04 | -5.30 | 0.40 | 3.30 | 9.70 | 36.06 | 17.01 | 17.51 | 53.41 | 56.27 | 52.61 | 88.37 | 75.03 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 17% | 12% | 13% | 10% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 28% |
| 3 Years: | 20% |
| TTM: | 41% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 33% |
| 5 Years: | 39% |
| 3 Years: | 18% |
| TTM: | -4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 61% |
| 5 Years: | 83% |
| 3 Years: | 52% |
| 1 Year: | 18% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 32% |
| 3 Years: | 30% |
| Last Year: | 32% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | -5 | -10 | -10 | -7 | 3 | 38 | 55 | 73 | 124 | 174 | 220 | 302 | 330 |
| 70 | 69 | 61 | 54 | 43 | 12 | 0 | 0 | 0 | 0 | 0 | 41 | 31 | |
| 31 | 26 | 30 | 20 | 29 | 48 | 24 | 37 | 49 | 68 | 71 | 73 | 91 | |
| Total Liabilities | 106 | 95 | 91 | 77 | 86 | 107 | 89 | 120 | 182 | 252 | 301 | 426 | 462 |
| 59 | 53 | 49 | 45 | 41 | 34 | 33 | 40 | 40 | 55 | 61 | 168 | 197 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 1 | 6 | 3 | 12 | 6 | 29 | 8 | 22 |
| Investments | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 23 | 42 | 67 | 67 | 9 | 9 |
| 46 | 42 | 42 | 31 | 44 | 71 | 49 | 55 | 88 | 124 | 145 | 242 | 234 | |
| Total Assets | 106 | 95 | 91 | 77 | 86 | 107 | 89 | 120 | 182 | 252 | 301 | 426 | 462 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19 | 9 | 16 | 16 | 17 | 37 | 22 | 37 | 44 | 43 | 34 | 33 | |
| -0 | 0 | -1 | -1 | -1 | -3 | -9 | -34 | -35 | -40 | -30 | -42 | |
| -19 | -10 | -15 | -15 | -17 | -34 | -12 | -1 | -5 | -6 | -7 | 32 | |
| Net Cash Flow | -0 | -0 | -0 | 0 | -0 | 0 | -0 | 2 | 5 | -3 | -3 | 23 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 56 | 52 | 54 | 46 | 44 | 38 | 40 | 40 | 28 | 49 | 59 | 65 |
| Inventory Days | 136 | 106 | 82 | 66 | 75 | 107 | 75 | 134 | 91 | 89 | 100 | 112 |
| Days Payable | 113 | 89 | 97 | 69 | 74 | 90 | 47 | 142 | 76 | 78 | 77 | 48 |
| Cash Conversion Cycle | 80 | 68 | 39 | 42 | 45 | 54 | 67 | 31 | 43 | 60 | 82 | 129 |
| Working Capital Days | -162 | -150 | -124 | -109 | -53 | 35 | 65 | 36 | 33 | 46 | 59 | 62 |
| ROCE % | 6% | 4% | 7% | 18% | 29% | 78% | 37% | 35% | 67% | 48% | 33% | 42% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 22 Jan
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
21 Jan - Q3 FY26: Revenue ₹174cr, EBITDA ₹26cr, PAT ₹16cr; 10,000t Solar Grade DHF commissioned; 20,000 TPA plant announced.
-
Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025.
21 Jan - Approved unaudited results for quarter and nine months ended Dec 31, 2025; limited review attached.
-
Board Meeting Intimation for Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025
14 Jan - Board meeting Jan 21, 2026 to approve unaudited Q3/9M results (ended Dec 31, 2025); trading window closed Jan 1–23.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
12 Jan - 7,500 tpa fluorinated chemicals supply; ₹337.5 crore/year, ₹2,362 crore over seven years; effective 1 Jan 2027.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Product Portfolio
The company manufactures inorganic fluorine-based chemicals like Anhydrous Hydrofluoric acid, Sulphuric Acid, Oleum, Aluminum Fluoride, Potassium Fluoride, Potassium Bifluoride, Boron Trifluoride Complexes, Calcium Sulphate (Gypsum), IsoButyl Acetophenone, Acetic Acid, Peracetic Acid and Poly Aluminum Chloride, etc. [1]